Patent ID: 11970491
Assignee: AUCENTRA THERAPEUTICS PTY LTD
Field: Organic fine chemistry (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 6:
7. The method of claim 4, wherein the proliferative cell disease or condition to be treated is selected from the group consisting of biliary tract cancer, brain cancer, cancers of the central nervous system, breast cancer, cervical cancer, choriocarcinoma, colonic cancer, endometrial cancer, oesophageal cancer, gastric cancer, haematological neoplasms, intraepithelial neoplasms, liver cancer, lung cancer, lymphomas, neuroblastomas, oral cancer, ovarian cancer, pancreatic cancer, prostate cancer, colorectal cancer, sarcomas, skin cancer, testicular cancer, stromal tumours, germ cell tumours, thyroid, and renal cancer.